Triple Negative Breast Cancer Drug Development Summit

The Triple Negative Breast Cancer Drug Development Summit is dedicated to improving the safety, efficacy & predictability of monotherapy & combinatorial therapies to fast-track the discovery & development of tnbc treatments to reach patients in need.

The Triple Negative Breast Cancer Drug Development Summit covers topics such as:

• Knowledge required to progress your own TNBC treatment by having the opportunity to hear from and network with KOLs
• The latest treatment options and the results coming out of the clinic